Oberweis Asset Management’s Phibro Animal Health PAHC Stock Holding History

Oberweis Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.77M	Buy	311,100 +34,000	+12%	+$1.43M	0.2%	132
2026 Q1	$15.3M	Buy	277,100 +67,300	+32%	+$3.2M	0.45%	88
2025 Q4	$7.84M	Buy	+209,800	New	+$8.52M	0.29%	125
2015 Q4	–	Sell	-15,400	Closed	-$487K	–	186
2015 Q3	$487K	Sell	15,400 -200	-1%	-$7.3K	0.14%	96
2015 Q2	$607K	Buy	15,600 +1,400	+10%	+$48.3K	0.16%	76
2015 Q1	$503K	Buy	+14,200	New	+$457K	0.14%	90

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Oberweis Asset Management's PAHC Position: Q2 2026 in Review

Oberweis Asset Management increased its Phibro Animal Health (PAHC) stake by 12% in Q2 2026, buying an estimated $1.43M and bringing the position to 311,100 shares worth $9.77M. The position accounts for 0.2% of the portfolio, ranked #132.

Oberweis Asset Management first reported a position in PAHC in Q1 2015 and has held it in 6 quarters since. The position peaked at $15.3M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Oberweis Asset Management held 311,100 shares of Phibro Animal Health worth $9.77M as of Q2 2026.
Oberweis Asset Management bought 34,000 Phibro Animal Health shares in Q2 2026, an estimated $1.43M.
Phibro Animal Health made up 0.2% of Oberweis Asset Management's portfolio in Q2 2026, its #132 holding.
Oberweis Asset Management first reported a position in Phibro Animal Health in Q1 2015 and has held it in 6 quarters since.
Oberweis Asset Management's Phibro Animal Health position peaked at $15.3M in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.